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Background
The family of the epithelio-tropic human papillomavirus
(HPV) comprises approximately 100 different types that
have been subgrouped in different genera according to
their genomic DNA sequence. In addition, the HPVs can
be subdivided in mucosal and cutaneous based on their
tissue tropism. Members of the genus alpha, referred to as
mucosal high-risk HPV types, have been clearly linked to
cervical cancer. Emerging lines of evidence indicate that
another group of HPVs belonging to the genus beta may
be involved in human carcinogenesis, i.e. non-melanoma
skin cancer (NMSC). Several independent studies have
suggested the involvement of mucosal HPV types in the
aetiology of human breast cancer, while others have
reported opposite findings. Here, we have analyzed the
prevalence of alpha mucosal and beta cutaneous HPV
types in 115 mammary fluids obtained by ductal lavages
from 90 women at elevated risk for breast cancer as deter-
mined by the presence of viral DNA. We also analyzed a
series of 25 colostrum and milk samples from women at
average risk.
Methods
Different highly sensitive and specific polymerase chain
reaction (PCR)-based protocols were used to detect DNA
from mucosal and cutaneous HPV in ductal lavages (DL)
obtained before (n = 70) or after removal of the superficial
layer of the nipple epidermis by tape (n = 45), as well as
form colostrum (n = 10) and milk (n = 25).
Results
Ten of the 70 DLs analyzed (14%) contained a single or
multiple beta HPV type. Together, these 10 specimens
contained 32 beta HPV DNAs. In contrast, DNA from
mucosal high-risk HPV types was detected in only one
sample (1/70). From the 45 DL fluids collected after
removal of the superficial layers of the nipple epidermis,
the DNA of only two beta HPV types was found in two
samples (4%). In contrast, the epidermis of the nipple
removed by the tape was strongly positive for beta cutane-
ous HPV types (90%). All 115 DLs were negative for the
mucosal low-risk HPV types 6 and 11. Finally, HPV posi-
tivity was low in colostrum and milk.
Conclusion
Our data show that DNA of alpha mucosa and beta cuta-
neous HPV types are rarely present in the breast fluids of
high-risk women, and suggest that a direct role of HPV in
breast carcinogenesis is unlikely. Ongoing studies are
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focused on the determination of other infectious agents in
DL, e.g. EMV and/or MMTV.